Obalon Therapeutics Announces Third Quarter Financial Results
Nov 11, 2016 12:00 pm UTC| Business
SAN DIEGO, Nov. 11, 2016 -- Obalon Therapeutics Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the...
Nov 11, 2016 12:00 pm UTC| Business
WALTHAM, Mass., Nov. 11, 2016 -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today presented...
Sprott Inc. Announces 2016 Third Quarter Results
Nov 11, 2016 12:00 pm UTC| Business
TORONTO, Nov. 11, 2016 -- Sprott Inc. (TSX:SII) (“Sprott” or the “Company”) today announced its financial results for the three months ended September30, 2016. 2016 Financial Overview Assets Under Management (“AUM”)...
Nov 11, 2016 12:00 pm UTC| Business
- ATLAS discovers neoantigens, through functional T cell responses, which were not identified by predictive algorithms - - Majority of antigens predicted by algorithms not biologically relevant in ATLAS assays - - Data...
Akari Therapeutics to Attend Upcoming Investor Conferences In November
Nov 11, 2016 12:00 pm UTC| Business
NEW YORK and LONDON, Nov. 11, 2016 -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that Dr. Gur Roshwalb, Chief Executive Officer, will attend and host...
Nov 11, 2016 12:00 pm UTC| Business
-- Biomarker Data Also Presented Indicating Evidence of Immune Activation-- --Data Presented at SITC’s 31st Annual Meeting--BURLINGAME, Calif., Nov. 11, 2016 -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a...
Nov 11, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2016 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...